Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study. Gui M, Zhan J, Li W, Jin T, He D, Tian D, Li Z, Lin J, Li Y, Zhou H, et al. Ann Clin Transl Neurol. 2026 Aug 23. PMID: 42634159. Abstract CommentRecommendBookmarkWatch
